Canton Strategic Holdings Inc
CNTN
NASDAQ
Biotechnology
$2.02
USD
+0.05 (+2.54%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $151.93M
Volume 741.7K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2026 |
|---|---|
Revenue | 0.0 |
YoY Growth | — |
Cost of Revenue | 0.0 |
Gross Profit | 0.0 |
Selling, General & Administrative | 36.6 |
Other Operating Expenses | 0.0 |
Total Operating Expenses | 36.9 |
Operating Income | -36.9 |
EBITDA | -36.9 |
Other Income / Expense | -15.0 |
Total Other Income / Expense | -14.7 |
Income Before Income Taxes | -51.6 |
Income Taxes | -4.2 |
Net Income | -47.3 |
Consolidated Net Income / Loss | -47.3 |
Net Income Attributable to Common Shareholders | -47.3 |
Basic EPS | -$0.23 |
Diluted EPS | -$0.23 |
Basic Shares Outstanding | 207.7M |
Diluted Shares Outstanding | 207.7M |